The ACI’s Regulatory Consultancy Team ensures our members are fully compliant in all regulatory aspects concerning CBD and other legal cannabinoids.
The Regulatory Consultancy Team provides a critical bridge between our members and the key regulatory bodies in the UK and Europe, whom we are in close and constant contact with.
With over 100 years of combined experience in the regulatory environment The ACI’s Regulatory Consultancy Team are ideally positioned to provide our members with the expertise, practical help and support they need to meet new and emerging regulatory compliance.
We provide a thorough gap analysis of your situation giving you a detailed checklist of any area where your business can be improved. With this information you maximise your chances of gaining the full legal compliance you require to enable you to keep your products on the market.
Bespoke novel food application consultancy
The ACI’s Consultancy Team can offer assistance in preparing, the now obligatory, novel foods scientific dossiers for each of your products. This way you can be confident that your novel foods applications cover everything required to gain the status of “novel foods validation” before the FSA’s 31st March 2021 deadline.
Regulatory Consultancy Team
Dr Parveen Bhatarah, Regulatory and Compliance Associate
Parveen has over 20 years experience in Pharmaceutical Innovation and international pharmaceutical regulatory experience (MHRA, TGA, ANVISA, EMA, Asia, and Chinese Health authorities). Moreover, Parveen has 12 years experience in the Medicinal Cannabis industry, covering everything from medicinal cultivation to FDA approval of finished products.
Dr Paul Duffy, Toxicology Associate
Over 30 years toxicology/safety evaluation experience in the pharmaceutical industry (ICI, Zeneca, AstraZeneca) over a wide range of therapeutic areas including cancer, inflammation, pain, infection, neuropsychopharmacological therapies. Responsible for the non-clinical safety programmes of potential new therapeutic agent development from discovery to drug registration across global territories including US/Canada, Europe, Japan and China.
A European Registered Toxicologist (ERT), a founding member of the In Vitro Toxicology Society and has served on committees of US Society of Toxicology and British Toxicology Society and is a Fellow of the BTS and a Fellow of the Royal Society of Biology. In 2015 Paul became an independent consultant and Associate of ApconiX Ltd with whom he is senior project toxicologist with particular experience in neuropsychopharmacology related therapeutics.
Penny Schenkel, Senior Regulatory Associate
Penny ran her own regulatory consultancy before joining the Resolution Chemicals team in 2017. Penny has held various regulatory roles in the generic and branded pharmaceutical industry and has accrued over 20 years of experience in pharmaceutical development, technology transfer and manufacture for European MAA applications. She has worked efficiently with multiple regulatory agencies across Europe and most recently focussing on the UK market.
Isabel Alber, Regulatory Associate
Isabel is a Food Scientist with 25 years experience in the Food Industry in all sectors and continents. She specialises in Food Safety and Quality Management Systems [ISO 9001, FSSC 22000, BRC, IFS], both in certification as an international third party auditor and as a Consultant in the UK and Europe, helping companies implement international standards and retailer’s codes of practice.
She has broad experience delivering training courses for both Third Party lead auditors and the implementation of Food Safety and Quality Systems.
Laura Eder, Regulatory Associate
Laura Eder has 17 years of experience in the life-cycle management of pharmaceuticals and medical devices and has had a Regulatory Affairs Certificate (RAC) since 2012. Based in Colorado, Laura held the position of Regulatory Manager at Mile High Labs (MHL). MHL were the first ACI members to submit their CBD novel foods dossier giving Laura first hand experience of this process. Laura also helped guide MHL through several significant regulatory milestones, including ISO 9001:2015, GMP 111 (dietary supplements) and GMP 117 (food) certifications. She has over 15 years experience in working with the FDA and brings a wealth of experience in all regulatory aspects relating to cannabinoids.
The ACI novel food consultancy
See The ACI’s novel foods consultancy page for further information on our consultancy services.
Get in touch
For more information on how to leverage this essential resource please contact us.